| 2023-03-28 | +0.56 % |
|
| 2023-03-24 | +0.58 % |
|
| 2023-03-23 | -0.27 % |
|
| 2023-03-22 | -1.58 % |
- Boston Scientific (BSX) stock went down by 1.58% after Vitrolife AB announced its proposed board members, including Henrik Blomquist, CEO of Bure Equity AB, and Lars Holmqvist, Chairman of the board in Biovica International AB, among others, for 2023.
- Boston Scientific's (BSX) stock went down by 1.58%, following concerns of the effects of another interest-rate increase by the Federal Reserve on banks, despite reportedly bullish signs in the healthcare sector due to a "steep ascent" starting, which according to Fundstrat's Head of Technical Strategy Mark Newton, bodes well for this part of healthcare to start showing better technical strength than what has been seen since early February.
|
| 2023-03-09 | +0.36 % |
|
| 2023-03-07 | -1.51 % |
|
| 2023-03-06 | -0.17 % |
|
| 2023-03-03 | +1.21 % |
|
| 2023-03-02 | +0.92 % |
|
| 2023-02-16 | -1.71 % |
|
| 2023-02-15 | +0.02 % |
|
| 2023-02-14 | -0.86 % |
|
| 2023-02-08 | -1.04 % |
|
| 2023-02-03 | +0.89 % |
|
| 2023-02-02 | +1.11 % |
|
| 2023-02-01 | +2.79 % |
|
| 2023-01-31 | +0.96 % |
|
| 2023-01-30 | -0.22 % |
|
| 2023-01-26 | +0.5 % |
|
| 2023-01-25 | +0.61 % |
|
| 2023-01-23 | +0.5 % |
|
| 2023-01-19 | +0.82 % |
|
| 2023-01-18 | -2.06 % |
|
| 2023-01-12 | +1.96 % |
|
| 2023-01-11 | -0.54 % |
|
| 2023-01-10 | +1.03 % |
|
| 2023-01-06 | +1.25 % |
|
| 2023-01-05 | -1.59 % |
|
| 2023-01-03 | -0.56 % |
|
| 2022-12-12 | +1.95 % |
|
| 2022-11-18 | +1.8 % |
|
